CAM
XFOR icon

ClariVest Asset Management’s X4 Pharmaceuticals XFOR Stock Holding History

ClariVest Asset Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,497
Closed -$289K – 811
2020
Q4 		$289K Sell
1,497
-26
-2% -$5.11K 0.01% 469
2020
Q3 		$309K Buy
1,523
+206
+16% +$49.4K 0.01% 413
2020
Q2 		$368K Sell
1,317
-80
-6% -$21.9K 0.01% 451
2020
Q1 		$419K Sell
1,397
-86
-6% -$24.4K 0.01% 417
2019
Q4 		$476K Buy
+1,483
New +$532K 0.01% 431

Other funds holding XFOR

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

ClariVest Asset Management's XFOR Position: Q1 2021 in Review

ClariVest Asset Management sold out of X4 Pharmaceuticals (XFOR) in Q1 2021, closing a stake of 1,497 shares — an estimated $289K sold.

ClariVest Asset Management first reported a position in XFOR in Q4 2019 and held it in 5 quarters. The position peaked at $476K in Q4 2019. 60 funds tracked by Wall St. Rank hold XFOR as of Q1 2021.

  • ClariVest Asset Management reported no remaining X4 Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • ClariVest Asset Management sold 1,497 X4 Pharmaceuticals shares in Q1 2021, an estimated $289K.
  • ClariVest Asset Management first reported a position in X4 Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • ClariVest Asset Management's X4 Pharmaceuticals position peaked at $476K in Q4 2019.
  • 60 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2021.

Based on ClariVest Asset Management's 13F filing for Q1 2021, filed 13 May 2021.